Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
for HER2 Expressing Solid Tumors
Sites in Hackensack +10 more locations
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All·Age: 18+
Code: NCT07192432·Phase 1, Phase 2·Recruiting·Listed Sep 2025
Paid Clinical Trials in Hackensack, NJ
As of September 2026, 306 paid clinical trials are recruiting in Hackensack, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
285 clinical trials
Get a weekly email when new trials open in Hackensack, NJ.
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
for Lung Cancer
Sites in Hackensack +12 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT06618287·Phase 1, Phase 2·Recruiting·Listed Oct 2024
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Hackensack +16 more locations
Sponsor: K36 Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05651932·Phase 1·Recruiting·Listed Dec 2022
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for Relapsed/Refractory Multiple Myeloma
Drug: Daratumumab
Sites in Hackensack +14 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT04973605·Phase 1, Phase 2·Recruiting·Listed Jul 2021
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
for Solid Tumors
Drug: INCB161734
Sites in Hackensack +12 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06179160·Phase 1·Recruiting·Listed Dec 2023
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
for Hematologic Malignancies
Drug: Nemtabrutinib
Sites in Hackensack, East Brunswick +5 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT04728893·Phase 2·Recruiting·Listed Jan 2021
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
for Cervical Cancer
Sites in Hackensack +7 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT04895709·Phase 1, Phase 2·Recruiting·Listed May 2021
A Long-term Follow-up Study in Patients Who Received BEAM-101
for Hemoglobinopathy
Sites in Hackensack +16 more locations
Sponsor: Beam Therapeutics Inc.
Sex: All·Age: 14 - 37
Code: NCT07373639·Recruiting·Listed Jan 2026
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Hackensack +14 more locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT06121843·Phase 1·Recruiting·Listed Nov 2023
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
for Solid Tumors
Sites in Hackensack +10 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05836324·Phase 1·Recruiting·Listed May 2023
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
for Hematologic Malignancies
Sites in Hackensack +10 more locations
Sponsor: Pulmotect, Inc.
Sex: All·Age: 18+
Code: NCT06665100·Phase 2·Recruiting·Listed Oct 2024
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
for Malignant Neoplasm
Sites in Hackensack +9 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06979596·Phase 2·Recruiting·Listed May 2025
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for Ovarian Cancer
Sites in Hackensack +12 more locations
Sponsor: NextCure, Inc.
Sex: All·Age: 18+
Code: NCT06774963·Phase 1·Recruiting·Listed Jan 2025
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
for Relapsed/Refractory Acute Myeloid Leukemia
Sites in Hackensack +17 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT06714591·Phase 1·Recruiting·Listed Dec 2024
A Study of LY4175408 in Participants With Advanced Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY4175408
Sites in Hackensack +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07046923·Phase 1·Recruiting·Listed Jul 2025
XTX301 in Patients With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Hackensack +9 more locations
Sponsor: Xilio Development, Inc.
Sex: All·Age: 18+
Code: NCT05684965·Phase 1, Phase 2·Recruiting·Listed Jan 2023
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
for Acute Myeloid Leukemia
Sites in Hackensack +7 more locations
Sponsor: Orca Biosystems, Inc.
Sex: All·Age: 12 - 78
Code: NCT03802695·Phase 1·Recruiting·Listed Jan 2019
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
for SCLC
Drug: ZL-1310
Sites in Hackensack +9 more locations
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All·Age: 18+
Code: NCT06179069·Phase 1·Recruiting·Listed Dec 2023
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Hackensack +13 more locations
Sponsor: ModernaTX, Inc.
Sex: All·Age: 12+
Code: NCT05533697·Phase 1, Phase 2·Recruiting·Listed Sep 2022
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
for Advanced Solid Tumor
Sites in Hackensack +2 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT04145622·Phase 1, Phase 2·Recruiting·Listed Oct 2019
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for Solid Tumor
Sites in Hackensack +10 more locations
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT07094204·Phase 1·Recruiting·Listed Jul 2025
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
for Focal Segmental Glomerulosclerosis
Drug: Sparsentan
Sites in Hackensack, Neptune City +15 more locations
Sponsor: Travere Therapeutics, Inc.
Sex: All·Age: 1 - 17
Code: NCT05003986·Phase 2·Recruiting·Listed Aug 2021
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
for Solid Tumor
Sites in Hackensack +14 more locations
Sponsor: NiKang Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06586957·Phase 1·Recruiting·Listed Sep 2024
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for Advanced Or Metastatic Merkel Cell Carcinoma
Sites in Hackensack, Morristown +16 more locations
Sponsor: TuHURA Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT06947928·Phase 2, Phase 3·Recruiting·Listed Apr 2025
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
for Myelodysplastic Syndromes
Drug: Venetoclax
Sites in Hackensack +21 more locations
Sponsor: Taiho Oncology, Inc.
Sex: All·Age: 18+
Code: NCT04256317·Phase 2, Phase 3·Recruiting·Listed Feb 2020
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
for Focal Onset Seizures
Drug: XEN1101
Sites in Hackensack +16 more locations
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT05716100·Phase 3·Recruiting·Listed Feb 2023
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for Peripheral T-Cell Lymphoma, Not Otherwise Specified
Drug: Soquelitinib
Sites in Hackensack +20 more locations
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06561048·Phase 3·Recruiting·Listed Aug 2024
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
for Ph+ ALL
Sites in Hackensack, New Brunswick +14 more locations
Sponsor: Ascentage Pharma Group Inc.
Sex: All·Age: 18+
Code: NCT06051409·Phase 3·Recruiting·Listed Sep 2023
Study of SGR-1505 in Mature B-Cell Neoplasms
for Mature B-Cell Neoplasm
Sites in Hackensack +15 more locations
Sponsor: Schrödinger, Inc.
Sex: All·Age: 18+
Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for Advanced Solid Tumor
Sites in Hackensack +20 more locations
Sponsor: Clasp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06778863·Phase 1·Recruiting·Listed Jan 2025
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
for Relapsed or Refractory T Cell Lymphoma
Sites in Hackensack +18 more locations
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT05079282·Phase 1·Recruiting·Listed Oct 2021
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for Chronic Lymphocytic Leukemia (CLL)
Drug: Venetoclax
Sites in Hackensack +10 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT04895436·Phase 2·Recruiting·Listed May 2021
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
for AML
Sites in Hackensack +20 more locations
Sponsor: TScan Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05473910·Phase 1·Recruiting·Listed Jul 2022
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
for Low Risk Myelodysplastic Syndromes
Sites in Hackensack +12 more locations
Sponsor: Rigel Pharmaceuticals
Sex: All·Age: 18+
Code: NCT05308264·Phase 1, Phase 2·Recruiting·Listed Apr 2022
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for Relapsed/Refractory Multiple Myeloma
Sites in Hackensack +15 more locations
Sponsor: Caribou Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT05722418·Phase 1·Recruiting·Listed Feb 2023
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
for Seizures
Drug: Carisbamate
Sites in Hackensack +6 more locations
Sponsor: SK Life Science, Inc.
Sex: All·Age: 4 - 55
Code: NCT05219617·Phase 3·Recruiting·Listed Feb 2022
Pivotal Study for the Cardiac Performance System (CPS)
for Cardiovascular Diseases
Sites in Hackensack, Neptune City +8 more locations
Sponsor: Sensydia Corporation
Sex: All·Age: 18+
Code: NCT06870591·Recruiting·Listed Mar 2025
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
for Follicular Lymphoma
Drug: Rituximab
Sites in Hackensack +4 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07634471·Phase 2, Phase 3·Recruiting·Listed Jun 2026
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
for Advanced Solid Tumor
Sites in Hackensack +9 more locations
Sponsor: Blueprint Medicines Corporation
Sex: All·Age: 18+
Code: NCT07629960·Phase 1, Phase 2·Recruiting·Listed Jun 2026
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
for Advanced Solid Cancer
Sites in Hackensack +3 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07607678·Phase 1·Recruiting·Listed May 2026